Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
46°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Recro Pharma Inc
(NQ:
REPH
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 21, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
1.600 (2)
Ask (Size)
2.300 (3)
Prev. Close
2.090
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
90,127,280
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Recro Pharma Earnings Perspective: Return On Capital Employed
March 07, 2022
According to data from Benzinga Pro, during Q4, Recro Pharma's (NASDAQ:REPH) reported sales totaled $22.30 million. Despite a 32.39% increase in earnings, the company posted a...
Via
Benzinga
Recap: Recro Pharma Q4 Earnings
March 01, 2022
Recro Pharma (NASDAQ:REPH) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Recro...
Via
Benzinga
Performance
More News
Read More
Earnings Scheduled For March 1, 2022
March 01, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 12, 2022
Via
Benzinga
5 Penny Stocks Insiders Are Buying
November 16, 2021
Via
Benzinga
Recro Secures Manufacturing Contract From NIH For Nasal Spray Analgesic
October 20, 2021
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Via
Benzinga
Exposures
Product Safety
Earnings Scheduled For May 6, 2021
May 06, 2021
Via
Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2021
October 12, 2021
Via
Benzinga
Recro Pharma's Return On Capital Employed Overview
September 16, 2021
Via
Benzinga
Recro and BioCorRx Expand Development and Manufacturing Relationship to Support BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
September 08, 2021
Via
NewMediaWire
Exposures
COVID-19
Product Safety
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 01, 2021
Via
Benzinga
60 Biggest Movers From Yesterday
August 17, 2021
Via
Benzinga
38 Stocks Moving In Monday's Mid-Day Session
August 16, 2021
Via
Benzinga
78 Biggest Movers From Friday
August 16, 2021
Via
Benzinga
Recro Pharma: Q2 Earnings Insights
August 09, 2021
Via
Benzinga
Earnings Scheduled For August 9, 2021
August 09, 2021
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 12, 2021
Via
Benzinga
70 Biggest Movers From Friday
May 10, 2021
Via
Benzinga
56 Stocks Moving In Friday's Mid-Day Session
May 07, 2021
Via
Benzinga
Earnings Preview for Recro Pharma
May 05, 2021
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
